Gene · 2224
Papers2,695
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,695
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathophysiology and therapeutic advances in myeloma bone disease. | Chronic Dis Transl Med | 2022 | 36420171 | PubTator, text mining | PubMed |
| Identification of novel prognostic biomarkers for osteosarcoma: a bioinformatics analysis of differentially expressed genes in the mesenchymal stem cells from single-cell sequencing data set. | Transl Cancer Res | 2022 | 36388032 | PubTator, text mining | PubMed |
| IFN-β mediates the anti-osteoclastic effect of bisphosphonates and dexamethasone. | Front Pharmacol | 2022 | 36386129 | PubTator, text mining | PubMed |
| APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. | Nature | 2022 | 36385529 | PubTator, text mining | PubMed |
| The why and how of sequential and combination therapy in osteoporosis. A review of the current evidence. | Arch Endocrinol Metab | 2022 | 36382762 | PubTator, text mining | PubMed |
| Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies. | Neurooncol Adv | 2022 | 36382110 | PubTator, text mining | PubMed |
| The Dietary and Non-Dietary Management of Osteoporosis in Adult-Onset Celiac Disease: Current Status and Practical Guidance. | Nutrients | 2022 | 36364816 | PubTator, text mining | PubMed |
| Biological Properties of Latex, Aqueous Extracts and Bee Products of Euphorbia officinarum L.: A Short Review. | Molecules | 2022 | 36364025 | PubTator, text mining | PubMed |
| A Mini Review on Osteoporosis: From Biology to Pharmacological Management of Bone Loss. | J Clin Med | 2022 | 36362662 | PubTator, text mining | PubMed |
| Deubiquitinase USP35 stabilizes BRPF1 to activate mevalonate (MVA) metabolism during prostate tumorigenesis. | Cell Death Discov | 2022 | 36357379 | PubTator, text mining | PubMed |
| Transcriptomic complexity of the human malaria parasite Plasmodium falciparum revealed by long-read sequencing. | PLoS One | 2022 | 36331983 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| MicroRNA-874 targets phosphomevalonate kinase and inhibits cancer cell growth via the mevalonate pathway. | Sci Rep | 2022 | 36323841 | PubTator, text mining | PubMed |
| The Biomechanical Stability of Bone Staples in Cortical Fixation of Tendon Grafts for Medial Collateral Ligament Reconstruction Depends on the Implant Design. | Am J Sports Med | 2022 | 36322386 | PubTator, text mining | PubMed |
| Customized Titanium Mesh for Guided Bone Regeneration in the Posterior Mandible in a Patient Previously Treated with Bisphosphonates. | Case Rep Dent | 2022 | 36317050 | PubTator, text mining | PubMed |
| Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease. | Drugs Context | 2022 | 36303600 | PubTator, text mining | PubMed |
| Synthesis of the biologically important dideuterium-labelled adenosine triphosphate analogue ApppI(d 2). | Beilstein J Org Chem | 2022 | 36300010 | PubTator, text mining | PubMed |
| Discovery of physalin biosynthesis and structure modification of physalins in Physalis alkekengi L. var. Franchetii. | Front Plant Sci | 2022 | 36299788 | PubTator, text mining | PubMed |
| Association between vitamin D and zoledronate-induced acute-phase response fever risk in osteoporotic patients. | Front Endocrinol (Lausanne) | 2022 | 36299453 | PubTator, text mining | PubMed |
| Combined Supplementation of Coenzyme Q10 and Other Nutrients in Specific Medical Conditions. | Nutrients | 2022 | 36297067 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2224/papers?page=20